Browsing Tag
Cardiovascular disease
28 posts
Can RNA interference expand beyond rare diseases through Tenaya–Alnylam cardiovascular research? (NASDAQ: ALNY, NASDAQ: TNYA)
Tenaya Therapeutics and Alnylam Pharmaceuticals partner to discover RNAi drug targets for cardiovascular disease. Read what this biotech deal could mean.
Could MediciNova’s MN-002 redefine how atherosclerosis is treated? Peer-reviewed study says yes
Learn how MediciNova’s MN-002 boosts macrophage cholesterol efflux and why scientists say it could transform atherosclerosis treatment.
Why is Novartis acquiring Tourmaline Bio—and how does pacibekitug fit into its cardiovascular pipeline?
Novartis is acquiring Tourmaline Bio in a $1.4B deal to advance pacibekitug, a promising anti-IL-6 therapy for atherosclerotic cardiovascular disease.
Understanding what tachycardia means and how a rapid heartbeat impacts your health
Discover what tachycardia is, what causes it, and how a fast heartbeat affects your heart health. Learn about types, symptoms, diagnosis, and treatment options.
Mended Hearts International Foundation to expand global cardiovascular patient advocacy from Geneva
Mended Hearts International Foundation launches in Geneva to drive global cardiovascular advocacy, peer support, and health policy reform through MHIN.
Lilly’s lepodisiran shows 94% reduction in lipoprotein(a), offering hope for cardiovascular risk management
Lilly’s lepodisiran slashed lipoprotein(a) by 94% in a Phase 2 trial. See how this breakthrough could change cardiovascular disease treatment.
Glenmark Pharmaceuticals expands cardiometabolic portfolio with new Empagliflozin drug launch
Glenmark Pharmaceuticals Ltd. has introduced Empagliflozin, a widely recognized SGLT2 inhibitor, in India under the brand name Glempa.…
Gene Hackman’s death confirmed as cardiovascular disease and Alzheimer’s, wife died from hantavirus
The cause of death of Academy Award-winning actor Gene Hackman and his wife, Betsy Arakawa, has been officially…
How a balanced diet and regular exercise can help prevent strokes
Adopting a healthy lifestyle remains the most effective strategy to prevent strokes and heart attacks. Scientific research consistently…
Sanofi strengthens cardiovascular portfolio with Aficamten rights in Greater China
Cytokinetics, Incorporated (NASDAQ: CYTK) saw its shares climb by 4.8% after announcing a landmark agreement with Sanofi (NASDAQ:…